Compliance with drug therapy for postmenopausal osteoporosis

被引:0
作者
D. Weycker
D. Macarios
J. Edelsberg
G. Oster
机构
[1] Policy Analysis Inc. (PAI),
[2] Four Davis Court,undefined
[3] Amgen,undefined
[4] Inc.,undefined
[5] Global Health Economics and Outcomes Research,undefined
来源
Osteoporosis International | 2006年 / 17卷
关键词
Adherence; Compliance; Osteoporosis; Pharmacotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1645 / 1652
页数:7
相关论文
共 89 条
[1]  
Andrade SE(2003)Low frequency of treatment of osteoporosis among postmenopausal women following a fracture Arch Intern Med 63 2052-2057
[2]  
Sumit RM(1997)Fractures attributable to osteoporosis: Report from the National Osteoporosis Foundation J Bone Miner Res 12 16-23
[3]  
Chan KA(2003)Comparing therapies for postmenopausal osteoporosis prevention and treatment Ann Pharmacother 37 744-746
[4]  
Buist DSM(2003)Older women with fractures: Patients falling through the cracks of guideline-recommended osteoporosis screening and treatment J Bone Joint Surg 85A 2294-2302
[5]  
Go AS(2002)Osteoporosis intervention following distal forearm fractures: A missed opportunity? Arch Intern Med 162 421-426
[6]  
Goodman M(2000)Treatment of osteoporosis: Are physicians missing an opportunity? J Bone Joing Surg 82-A 1063-1070
[7]  
Melton LJ(2005)Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women Mayo Clin Proc 80 856-861
[8]  
Thamer R(2004)The impact of compliance with osteoporosis therapy on fracture rates in actual practice Osteoporos Int 15 1003-1008
[9]  
Ray NF(2004)Compliance with drug therapies for the treatment and prevention of osteoporosis Maturitas 48 271-287
[10]  
Eichner SF(2001)Postmenopausal hormonal support: Discontinuation of raloxifene versus estrogen Menopause 8 328-3321